Alembic Limited

NSE ALEMBICLTD.NS

Alembic Limited Interest Coverage Ratio for the year ending March 31, 2024: 88.09

Alembic Limited Interest Coverage Ratio is 88.09 for the year ending March 31, 2024, a 23.19% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Alembic Limited Interest Coverage Ratio for the year ending March 31, 2023 was 71.51, a 206.89% change year over year.
  • Alembic Limited Interest Coverage Ratio for the year ending March 31, 2022 was 23.30, a 18.33% change year over year.
  • Alembic Limited Interest Coverage Ratio for the year ending March 31, 2021 was 19.69, a -93.91% change year over year.
  • Alembic Limited Interest Coverage Ratio for the year ending March 31, 2020 was 323.49, a 56.55% change year over year.
Key data
Date Interest Coverage Ratio Debt to Equity Ratio Interest Expense To Sales Inventory Turnover Ratio
Market news
Loading...
NSE: ALEMBICLTD.NS

Alembic Limited

CEO Ms. Malika Chirayu Amin
IPO Date July 1, 2002
Location India
Headquarters Alembic Road
Employees 285
Sector Health Care
Industries
Description

Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). It operates through API and Real Estate segments. The company is also involved in the construction of residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. In addition, it operates co-generation plants with a total capacity of 11 MW; and wind power plants with a total capacity of 5 MW. The company also exports its products. Alembic Limited was founded in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Limited.

Similar companies

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 26.96

3.45%

BLISSGVS.NS

Bliss GVS Pharma Limited

USD 1.89

4.04%

AARTIDRUGS.NS

Aarti Drugs Limited

USD 4.85

-0.49%

APLLTD.NS

Alembic Pharmaceuticals Limited

USD 11.66

0.86%

BALMLAWRIE.NS

Balmer Lawrie & Co. Ltd.

USD 2.30

1.13%

StockViz Staff

January 16, 2025

Any question? Send us an email